CV Sciences, Inc. (CVSI) Q3 2025 Earnings Call Prepared Remarks Transcript
Source: SeekingAlpha
2025-11-13 18:01:40 ET
CV Sciences, Inc. (CVSI) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST
Company Participants
Brendan Hawkins
Joseph Dowling - CEO, Secretary & Director
Joerg Grasser - Chief Financial Officer
...
Read the full article on Seeking Alpha
For further details see:
CV Sciences, Inc. (CVSI) Q3 2025 Earnings Call Prepared Remarks Transcript
CV Sciences Inc.
NASDAQ: CVSI
CVSI Trading
-13.29% G/L:
$0.0607 Last:
106,437 Volume:
$0.0624 Open:
CVSI Latest News
February 26, 2026 08:30:00 am
CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness
December 22, 2025 07:00:00 pm
CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD
November 10, 2025 06:15:00 pm
CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025
CVSI Stock Data
$6,817,756
177,261,643
0.54%
5
N/A
Pharmaceuticals
Healthcare
US
San Diego
